GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Acer Medical 6857.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

90.00

—

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 60.1m

FY2019FY2025

Net income

−TWD 29.7m

FY2019FY2025

Free cash flow

−TWD 25.7m

FY2019FY2025

Shareholders' equity

TWD 164.9m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueTWD 60.1mTWD 50.2mTWD 27.4mTWD 13.1mTWD 9.6mTWD 1.0m—
Gross profitTWD 37.5mTWD 31.7mTWD 12.9mTWD 6.1mTWD 6.4mTWD 343,000—
Research and developmentTWD 29.9mTWD 26.8mTWD 20.5mTWD 26.3mTWD 13.6mTWD 11.0m—
Operating income−TWD 32.7m−TWD 30.2m−TWD 41.2m−TWD 55.2m−TWD 20.4m−TWD 12.0m—
Net income−TWD 29.7m−TWD 27.4m−TWD 38.2m−TWD 54.7m−TWD 20.4m−TWD 11.9m−TWD 5.6m
Diluted earnings per share-1.95-1.80-2.51-4.32-2.64-2.29-1.08

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsTWD 207.2mTWD 226.9mTWD 259.4mTWD 290.2mTWD 136.7mTWD 43.5m—
Cash and short-term investments—TWD 202.8mTWD 220.0mTWD 276.6mTWD 129.7mTWD 43.4m−TWD 89,000
Total liabilitiesTWD 42.3mTWD 32.3mTWD 37.5mTWD 30.0mTWD 21.9mTWD 14.3mTWD 89,000
Debt—TWD 85,000TWD 4,000———TWD 89,000
Shareholders' equityTWD 164.9mTWD 194.6mTWD 221.9mTWD 260.1mTWD 114.8mTWD 29.2m—
Shares outstanding15m15m15m13m8m5m5m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−TWD 24.6m−TWD 20.7m−TWD 53.1m−TWD 45.8m−TWD 18.8m−TWD 3.6m−TWD 2.8m
Capital spending−TWD 1.1m—−TWD 762,000−TWD 7.4m−TWD 865,000——
Free cash flow−TWD 25.7m−TWD 20.7m−TWD 53.9m−TWD 53.2m−TWD 19.7m−TWD 3.6m−TWD 2.8m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 30.1mTWD 25.0mTWD 25.2mTWD 20.1mTWD 7.3mTWD 7.2mTWD 5.8mTWD 4.8m
Gross profitTWD 18.3mTWD 14.1mTWD 17.1mTWD 8.9mTWD 4.0mTWD 3.1mTWD 3.0mTWD 3.2m
Operating income−TWD 16.6m−TWD 16.5m−TWD 13.7m−TWD 19.1m−TWD 22.1m−TWD 25.6m−TWD 29.5m−TWD 10.2m
Net income−TWD 15.1m−TWD 15.2m−TWD 12.2m−TWD 17.5m−TWD 20.7m−TWD 25.3m−TWD 29.4m−TWD 10.2m
Diluted earnings per share-0.99-1.00-0.80-1.15-1.36-2.00-2.32-1.32
Cash from operations−TWD 19.0m−TWD 4.0m−TWD 16.0m−TWD 29.0m−TWD 23.0m−TWD 23.0m−TWD 22.0m−TWD 9.0m
Capital spending—−TWD 4.0m−TWD 33.0m——−TWD 2.0m——
Free cash flow—−TWD 8.0m−TWD 49.0m——−TWD 25.0m——
Total assetsTWD 209.5mTWD 226.9mTWD 243.8mTWD 259.4mTWD 264.5mTWD 290.2m—TWD 136.7m
Cash and short-term investmentsTWD 182.3mTWD 202.8mTWD 207.0mTWD 220.0mTWD 253.0mTWD 276.6m—TWD 129.7m
DebtTWD 233,000TWD 85,000TWD 80,000TWD 4,000————
Shareholders' equityTWD 179.4mTWD 194.6mTWD 209.7mTWD 221.9mTWD 239.5mTWD 260.1m—TWD 114.8m

Financial ratios

Data as of 2 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin62.4%63.1%46.9%47.0%66.9%33.8%
Operating margin-49.4%-60.2%-150.0%-422.5%-212.4%-1175.9%
Net margin-49.4%-54.6%-139.1%-418.9%-212.4%-1176.0%
Return on equity-18.0%-14.1%-17.2%-21.0%-17.8%-40.8%
Return on assets-14.3%-12.1%-14.7%-18.9%-15.0%-27.4%
Free cash flow yield-1.8%-1.5%-3.9%-4.1%-2.7%-0.8%
Revenue growth19.7%82.7%110.2%35.7%849.4%—
Earnings growth8.5%-28.3%-30.2%167.6%71.5%111.8%
Current ratio4.74x6.84x6.66x9.41x6.19x3.04x
Debt to equity—0.00x0.00x———
Equity ratio79.6%85.8%85.5%89.6%83.9%67.1%
Interest coverage-2282.54x————-11924.00x
R&D as a share of sales49.9%53.5%74.8%201.4%141.6%1080.0%
Buybacks as a share of market value0.0%0.0%-20.2%-63.4%-49.0%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue66.3%126.2%—
Operating income-16.0%22.2%—
Net income-18.4%20.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin62.8%58.5%58.9%—
Operating margin-57.1%-105.7%-118.8%—
Net margin-51.8%-99.5%-113.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-50.8-79.0-73.8-16.9
Price to sales25.143.1102.670.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.